Comparison of Success Rate Between Distal Radial Approach and Radial Approach in STEMI
1 other identifier
interventional
352
1 country
3
Brief Summary
ST-segment elevation myocardial infarction (STEMI) is an emergent disease to treat as soon as possible. 2017 ESC guidelines for the management of STEMI recommend using radial approach (RA) rather than femoral approach (FA) to reduce mortality and bleeding complications if the operators are expert for RA. Recently, Ferdinand Kiemeneij reported that distal radial approach (DRA) could be a feasible and safe route for coronary angiography (CAG) and percutaneous coronary intervention (PCI) in 70 patients. The right-handed patient could feel more comfortable in left DRA than right RA. Left DRA also could provide a better comfortable position for the operator compared to left RA. Distal radial artery is located around the anatomical snuffbox, which doesn't contain nerve and vein beside artery. Therefore, the possibility of procedure-related complications such as nerve injury or arteriovenous fistula is very low. Also, the superficial location of DRA could make easier hemostasis. There were no vascular-related complications from the report of Kiemeneij. But, the rate of puncture failure was 11%, which was higher than RA-based study (5.34% in STEMI patients of RIVAL trial, 6% in RIFLESTEACS trial and 5.8% in MATRIX trial). Nevertheless, this study was a pilot study with a small number of patients. There is no clinical study to compare the feasibility and safety for CAG and PCI between DRA and RA in patients with STEMI. Therefore, this study aimed to evaluate whether DRA is feasible and safe compared to RA in STEMI setting.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Aug 2018
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2018
CompletedFirst Posted
Study publicly available on registry
August 2, 2018
CompletedStudy Start
First participant enrolled
August 15, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2023
CompletedAugust 22, 2025
August 1, 2025
4.6 years
July 17, 2018
August 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Puncture success rate (%)
The success rate (%) of arterial puncture will be compared between distal radial artery approach and radial artery approach group.
Through procedure completion, up to 6 hours
Secondary Outcomes (9)
Success rate of coronary angiography (%)
Through procedure completion, up to 6 hours
Success rate of percutaneous coronary intervention (%)
Through procedure completion, up to 6 hours
Procedure success rate (%)
Through procedure completion, up to 6 hours
Bleeding complication rate (%)
During hospitalization, up to 1 month
Total procedure time (minutes)
Through procedure completion, up to 6 hours
- +4 more secondary outcomes
Study Arms (2)
Distal radial artery
ACTIVE COMPARATORAfter subcutaneous injection of lidocaine, the distal radial artery around the bony surface area is punctured with a 20-gauge venipuncture catheter needle or steel needle according to the operator's discretion. After successful puncture, flexible, straight plastic 0.025" mini-guidewire is inserted through the hole of the puncture needle. Then, Radifocus® introducer sheath (Terumo, Tokyo, Japan) is inserted into the distal radial artery.
Radial artery
PLACEBO COMPARATORAfter subcutaneous injection of lidocaine, the radial artery is punctured with a 20-gauge venipuncture catheter needle or steel needle according to the operator's discretion. After successful puncture, flexible, straight plastic 0.025" mini-guidewire is inserted through the hole of the puncture needle. Then, Radifocus® introducer sheath (Terumo, Tokyo, Japan) is inserted into the radial artery.
Interventions
The distal radial artery will be punctured with a puncture needle. Then, coronary angiography and percutaneous coronary intervention will be performed.
The radial artery will be punctured with a puncture needle. Then, coronary angiography and percutaneous coronary intervention will be performed.
Eligibility Criteria
You may qualify if:
- Age ≥ 20 years
- ST-segment elevation myocardial infarction
- Palpable unilateral distal radial and radial artery
You may not qualify if:
- Cardiogenic shock
- Thrombolysis before primary percutaneous coronary intervention
- Inability to obtain written informed consent
- Patient with ipsilateral arteriovenous fistula
- Participation in another ongoing clinical trial
- Pregnancy
- Expected lifespan \<12 months
- \* Eligible operator criteria
- Qualified operator who had experienced ≥ 100 cases of distal radial artery puncture
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Wonju Severance Christian Hospitallead
- Hanmi Pharmaceutical co., ltd.collaborator
Study Sites (3)
Kangwon National University College of Medicine
Chuncheon, Gangwon-do, South Korea
Wonju Severance Christian Hospital
Wŏnju, Gangwon-do, 26426, South Korea
The Catholic university of Korea Uijeongbu St. Mary's hospital
Uijeongbu-si, Gyeonggi-do, South Korea
Related Publications (1)
Lee JW, Kim CJ, Lee BK, Ahn SG, Youn YJ, Lee JH, Jeon HS, Kim SY, Jang J, Bu S, Ahn HS, Lim S, Yim HW, Lee SH. Distal Radial Access vs Transradial Access in Patients With ST-Segment Elevation Myocardial Infarction: The DRAMI Trial. JACC Adv. 2025 Nov;4(11 Pt 1):102200. doi: 10.1016/j.jacadv.2025.102200. Epub 2025 Sep 29.
PMID: 41027079DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Seung-Hwan Lee, MD
Yonsei University Wonju College of Medicine, Wonju Severance Christian Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 17, 2018
First Posted
August 2, 2018
Study Start
August 15, 2018
Primary Completion
March 7, 2023
Study Completion
December 13, 2023
Last Updated
August 22, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share